CARE Ratings freezes at 20% upper circuit on heavy volumes post Q2 results

The board has approved the payment of an interim dividend of Rs 8 per equity share of the face value of Rs 10 each for the financial year 2020-21.

Ratings, credit rating agency
CARE Ratings reported a nearly four-fold jump in its consolidated net profit at Rs 35.84 crore in Q2FY21 over the previous quarter.
SI Reporter Mumbai
3 min read Last Updated : Nov 04 2020 | 12:06 PM IST
Shares of CARE Ratings were locked in the upper circuit limit of 20 per cent at Rs 365 on the BSE on Wednesday on the back of heavy volumes after the company reported a good set of July-September (Q2FY21) numbers.

The trading volumes on the counter jumped over 15-times with a combined 6.29 million shares, representing 21 per cent of the total equity of the rating company, changed hands on the NSE and BSE till 11:32 am. There were a combined pending buy orders for around 400,000 shares on both the exchanges, data shows.

CARE Ratings reported a nearly four-fold jump in its consolidated net profit at Rs 35.84 crore in Q2FY21 over the previous quarter. It had posted a profit of Rs 9.69 crore in Q1FY21. Revenue from operations more-than-doubled to Rs 75.87 crore from Rs 37.38 crore in the previous quarter.

“We are seeing sequential improvement in some of the high frequency monthly economic indicators which are on expected lines as we do expect quarterly GDP growth to improve over Q1 and turn marginally positive in Q4,” said Ajay Mahajan, MD & CEO of CARE Ratings.

“The announcement of on-tap TLTROs and the government's additional spending on capex should help to revive private investment and we would be keenly watching whether this will lead to more differentiated issuances in the bond market which is still biased towards the financial sector,” he added.

For the first half (April-September) of the financial year 2020-21, the rating agency’s consolidated profit after tax declined 4 per cent to Rs 47.94 crore, while operational revenue fell 5 per cent to Rs 113 crore, over the same period of the previous fiscal.

The board has approved the payment of an interim dividend of Rs 8 per equity share of the face value of Rs 10 each for the financial year 2020-21.

The company said in a regulatory filing on Tuesday that the macro-economic environment, though improving since June due to the unlock measures, is still in the negative territory as evidenced by the growth in credit to manufacturing and services which are the quick indicators of economic activity.

Within manufacturing, growth in credit to large industry declined by 5.1 per cent while that to micro, small and medium increased due to the guarantee support provided by the government. Further, with the industry having surplus capacity with the utilisation rate being 47.3 per cent in June investment level was low. Therefore, fresh investment in this sector would be delayed until utilisation rates reach the optimal level. Corporate bond issuances were higher while commercial paper (CP) issuances lower.

Despite a sharp run-up today, the stock of CARE Ratings has underperformed the market by falling 15 per cent, against a 7 per cent gain in the S&P BSE Sensex in the past three months.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CARE RatingsBuzzing stocksMarkets

Next Story